{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:06:07Z","timestamp":1767899167010,"version":"3.49.0"},"reference-count":18,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,8,19]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>Idiopathic hypereosinophilic syndrome is characterised by the overproduction of eosinophils with tissue infiltration, leading to multiorgan dysfunction. Its heterogenous presentation makes the diagnosis challenging and easy to miss. A woman in her 70s was admitted with chest pain and shortness of breath. Diagnostic testing showed elevated cardiac enzymes, an ejection fraction of 45% and pericardial effusion. Pericardiocentesis helped her symptoms significantly. Cardiac catheterisation revealed patent coronary arteries. She was diagnosed with myopericarditis and discharged on non-steroidal anti-inflammatory drugs. She returned the following week with worsening chest pain, dyspnoea and diarrhoea. Chest imaging showed bilateral infiltrates. Diagnostic testing showed eosinophilic predominance in peripheral blood (59%), pericardial fluid (37%) and bronchoalveolar lavage (31%). After a negative infectious workup, she was started on glucocorticoids and responded favourably. She was discharged on steroids. Mepolizumab was initiated outpatient, and steroids were discontinued. Mepolizumab was discontinued after 2\u2009years while monitoring her symptoms and eosinophil counts.<\/jats:p>","DOI":"10.1136\/bcr-2023-256274","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T12:11:50Z","timestamp":1693397510000},"page":"e256274","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Idiopathic hypereosinophilic syndrome presenting as cardiac tamponade and multiorgan dysfunction"],"prefix":"10.1136","volume":"16","author":[{"given":"Kelly","family":"Roth","sequence":"first","affiliation":[{"name":"Internal Medicine, Carle Foundation Hospital, Urbana, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8544-3980","authenticated-orcid":false,"given":"Sushan","family":"Gupta","sequence":"additional","affiliation":[{"name":"Internal Medicine, Carle Foundation Hospital, Urbana, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishesh","family":"Paul","sequence":"additional","affiliation":[{"name":"Pulmonary and critical care medicine, Carle Foundation Hospital, Urbana, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyank","family":"Patel","sequence":"additional","affiliation":[{"name":"Hematology & Oncology, Carle Foundation Hospital, Urbana, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"key":"2025082723014465000_16.8.e256274.1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3341"},{"key":"2025082723014465000_16.8.e256274.2","doi-asserted-by":"crossref","first-page":"100809","DOI":"10.1016\/j.blre.2021.100809","article-title":"Hypereosinophilic syndromes - an enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment","volume":"49","author":"Helbig","year":"2021","journal-title":"Blood Rev"},{"key":"2025082723014465000_16.8.e256274.3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/ajh.25617","article-title":"World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management","volume":"94","author":"Shomali","year":"2019","journal-title":"Am J Hematol"},{"key":"2025082723014465000_16.8.e256274.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-551614"},{"key":"2025082723014465000_16.8.e256274.5","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajh.24880","article-title":"World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gotlib","year":"2017","journal-title":"Am J Hematol"},{"key":"2025082723014465000_16.8.e256274.6","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J"},{"key":"2025082723014465000_16.8.e256274.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0006"},{"key":"2025082723014465000_16.8.e256274.8","unstructured":"Kanuru S , Sapra A . Eosinophilia. Treasure Island (FL): StatPearls, 2023."},{"key":"2025082723014465000_16.8.e256274.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.022"},{"key":"2025082723014465000_16.8.e256274.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2015.01.006"},{"key":"2025082723014465000_16.8.e256274.11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009487","article-title":"Eosinophilic myocarditis: classic presentation of elusive disease","volume":"12","author":"Kassem","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025082723014465000_16.8.e256274.12","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890290125019"},{"key":"2025082723014465000_16.8.e256274.13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014532","article-title":"Idiopathic hypereosinophilic syndrome presenting with multiple organ damage: a case report","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2025082723014465000_16.8.e256274.14","article-title":"Eosinophilic myocarditis presenting as cardiac tamponade: a diagnostic challenge","volume":"9","author":"Vo","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"2025082723014465000_16.8.e256274.15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00246-003-0664-3","article-title":"Eosinophilic pericarditis: a rare complication of idiopathic hypereosinophilic syndrome in a child","volume":"25","author":"Spiegel","year":"2004","journal-title":"Pediatr Cardiol"},{"key":"2025082723014465000_16.8.e256274.16","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jaip.2017.08.001","article-title":"Biologic agents for the treatment of hypereosinophilic syndromes","volume":"5","author":"Kuang","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025082723014465000_16.8.e256274.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.055"},{"key":"2025082723014465000_16.8.e256274.18","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jaip.2018.04.033","article-title":"Long-term clinical outcomes of high-dose mepolizumab treatment for hypereosinophilic syndrome","volume":"6","author":"Kuang","year":"2018","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-256274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:01:56Z","timestamp":1756360916000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-256274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":18,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,30]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/bcr-2023-256274"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-256274","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}